Corporate News Releases

Applied Biomedicals Appoints Dean Petkanas to Executive Board

Placentia, CA – June 30, 2025 —Applied Biomedicals is proud to announce the appointment of Mr. Dean Petkanas to its Executive Board, marking a significant step forward in the company’s commitment to advancing breakthrough biomedical technologies through strategic leadership and innovation-driven growth.

Applied Biomedicals Appoints Dr. Roscoe M. Moore, Jr. to Executive Board

Placentia, CA – June 30, 2025 — Applied Biomedicals is honored to announce the appointment of Dr. Roscoe M. Moore, Jr., D.V.M., Ph.D., D.Sc. (Hon.) to its Executive Board, further strengthening the company’s leadership in global health strategy, translational diagnostics, and evidence-based medical innovation.

Applied Biomedicals Appoints Dr. Roberto Pietro Antonacci, M.D. to Executive Board

Placentia, CA June 27, 2025 – Applied Biomedicals is proud to announce the appointment of Dr. Roberto Pietro Antonacci, M.D. to its Executive Board, marking a significant milestone in the company’s mission to advance innovation in diagnostic medicine, precision imaging, and patient-centered care.

Dr. Roberto Pietro Antonacci Joins Applied Biomedical as Chief Medical Officer and as member of the Scientific Advisory Board

Lake Grove, NY – October 28th, 2024 – Applied Biomedical, a leading innovator in medical biotechnology, is proud to announce the appointment of Roberto Pietro

Applied Biomedical is pleased to announce the appointment of Dean Petkanas as Interim Chief Executive Officer

Dean Petkanas is a corporate finance and executive management professional with over 25 years of investment banking and capital markets experience. In 2010 Mr. Petkanas

Infectious Disease Updates

Global TB Surge: A 2025 Wake-Up Call to Strengthen Detection and Response

Global Health Update: WHO Introduces Game-Changing Treatment for Drug-Resistant Tuberculosis

Whole Genome Sequencing Enhances Understanding of Drug-Resistant Tuberculosis

Tuberculosis on the Rise: A Closer Look at the 2024–2025 Kansas Outbreak

Next Generation of Rapid Diagnostics

Applied BioMedical (ABM) is developing the next generation of essential, rapid, point of care diagnostics for infectious disease and oncology

Drug-Resistant Tuberculosis: Elevated Risk Among Military Personnel in the Philippines

1 2 3